Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Evaluate how withdrawal sequencing differs between IRA and taxable accounts for index funds. Get a practical plan to optimize after-tax income.
21,351 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Trump’s historic line about abandoning nation-building now echoes into a markets-focused era. This piece explains wha...
Applied Optoelectronics has jumped as AI buyers chase fast, fiber-based connectivity. The stock rally highlights how ...
A top institutional trader doubled down on PTCT, adding thousands of shares in a high-conviction move. This analysis ...
Ripple reveals an AI-driven security upgrade for the XRP Ledger after a batch-transaction bug. The move aims to harde...
Bitcoin again cannot break the $71,500 ceiling, underscoring a stubborn resistance amid a broader risk-off shift. The...
The Pentagon designated Anthropic as a supply-chain risk, triggering an immediate halt to certain contracts and a six...
Bitcoin has seen wild swings, but could it really go to zero? This guide breaks down probabilities, failure scenarios...
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
Taxpayers face longer waits for refunds as agencies update forms for new rules and software. New York and Idaho highl...
Ethereum faces a potential slide toward $1,500 by the end of the third quarter if bearish momentum persists. CryptoQu...